Cargando…
Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features
BACKGROUND: A trough concentration of >20 mg/L is considered the optimal dosage of teicoplanin required to ensure early therapeutic effects against methicillin-resistant Staphylococcus aureus (MRSA) infections including those in patients who develop febrile neutropenia after chemotherapy. This st...
Autores principales: | Seki, Masafumi, Yabuno, Kaori, Miyawaki, Koji, Miwa, Yoshihiro, Tomono, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516451/ https://www.ncbi.nlm.nih.gov/pubmed/23236257 http://dx.doi.org/10.2147/CPAA.S37528 |
Ejemplares similares
-
High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno, Kaori, et al.
Publicado: (2013) -
Construction and Interpretation of Prediction Model of Teicoplanin Trough Concentration via Machine Learning
por: Ma, Pan, et al.
Publicado: (2022) -
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections
por: Zhou, Lijuan, et al.
Publicado: (2018) -
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections [Corrigendum]
Publicado: (2019) -
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
por: Ueda, Takashi, et al.
Publicado: (2020)